Marijke van den Berg

2.4k citations

24 papers · 1.8k indexed · 1 hit paper · h-index 16

Co-authors: Eveline P. Mauser‐Bunschoten I.R.O. Nováková Bert Verbruggen H. Wessels J.B.M. Boezeman G. Roosendaal Pia Petrini Floris P. J. G. Lafeber
Topics: Hemophilia Treatment and Research (18 papers)Blood Coagulation and Thrombosis Mechanisms (8 papers)Platelet Disorders and Treatments (7 papers)
Cited by: Hematology Genetics Internal Medicine
Journals: Blood American Journal Of Pathology Thrombosis and Haemostasis
Partner nations: Netherlands Sweden Germany

In The Last Decade

Marijke van den Berg

22 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Nijmegen Modification of the Bethesda Assay for Factor VIII:C Inhibitors: Improved Specificity and Reliability

1995 500 citations Bert Verbruggen, I.R.O. Nováková et al. Thrombosis and Haemostasis profile →

Peers

Countries citing papers authored by Marijke van den Berg

Since Specialization

Citations

This map shows the geographic impact of Marijke van den Berg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marijke van den Berg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marijke van den Berg more than expected).

Fields of papers citing papers by Marijke van den Berg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marijke van den Berg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marijke van den Berg. The network helps show where Marijke van den Berg may publish in the future.

Co-authorship network of co-authors of Marijke van den Berg

This figure shows the co-authorship network connecting the top 25 collaborators of Marijke van den Berg. A scholar is included among the top collaborators of Marijke van den Berg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marijke van den Berg. Marijke van den Berg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Predictors of immune tolerance induction success in 231 children with severe hemophilia A with high-titer inhibitors – lessons learned from the PedNet prospective cohort study 2025 ·Journal of Thrombosis and Haemostasis ·Manuel Carção,Christoph Königs,Nadine G. Andersson,(unknown),(unknown),(unknown),Jan Blatný,Martin Olivieri,Marijke van den Berg,(unknown)	0
2	Inhibitor incidence in an unselected cohort of previously untreated patients with severe haemophilia B: a PedNet study 2020 ·Haematologica ·Christoph Male,Nadine G. Andersson,Anne Rafowicz,Ri Liesner,Karin Kurnik,Kathelijn Fischer,Helen Platokouki,Elena Santagostino,Hérvè Chambost,Beatrice Nolan,Christoph Königs,Gili Kenet,Rolf Ljung,Marijke van den Berg,(unknown)	77
3	The Fourth Annual Meeting of the International Network for Pediatric Hemophilia: Current Challenges and Recommendations in the Clinical Care of Children with Hemophilia 2010 ·Transfusion Medicine and Hemotherapy ·Rolf Ljung,Marijke van den Berg,Leonard A. Valentino,M L Manco-Johnson	5
4	Risk of Inhibitor Development in Children with Haemophilia A 2007 ·European Oncology & Haematology ·Marijke van den Berg	1
5	Hemophilia joint health score reliability study 2006 ·Haemophilia ·Pamela Hilliard,Sharon Funk,N. Zourikian,(unknown),(unknown),M. McLimont,Marilyn J. Manco‐Johnson,Pia Petrini,Marijke van den Berg,Brian M. Feldman	275
6	Managing the Pediatric Patient and the Adolescent/Adult Transition 2006 ·Seminars in Thrombosis and Hemostasis ·Leonard A. Valentino,Elena Santagostino,Victor S. Blanchette,Marijke van den Berg	2
7	O-Linked Glycosylation with Sialylated T-Antigen: A Novel Carbohydrate Determinant of von Willebrand Factor Antigen Levels. 2006 ·Blood ·Peter J. Lenting,(unknown),Ton Lisman,Marijke van den Berg,Jeroen Eikenboom,Frank W.G. Leebeek,Jenny Goudemand,Édith Fressinaud,Philip G. de Groot,Cécile V. Denis	2
8	Cost effectiveness of haemophilia treatment: a cross-national assessment 2005 ·Blood Coagulation & Fibrinolysis ·Barbara Lippert,Karin Berger,Erik Berntorp,Paul Giangrande,Marijke van den Berg,Wolfgang Schramm,Uwe Siebert	43
9	Outcome measures in haemophilia: more than just factor levels 2004 ·Haemophilia ·Rhonda L. Bohn,W. Schramm,Monika Bullinger,Marijke van den Berg,Victor S. Blanchette	17
10	Physical therapy and imaging outcome measures in a haemophilia population treated with factor prophylaxis: current status and future directions 2004 ·Haemophilia ·M. J. Manco‐Johnson,H. Pettersson,Pia Petrini,(unknown),(unknown),(unknown),Andrea Doria,B. M. Feldman,Sharon Funk,Pamela Hilliard,Ray F. Kilcoyne,(unknown),Rachelle Nuss,Georges‐Étienne Rivard,Marja Schoenmakers,Marijke van den Berg,Jerome D. Wiedel,N. Zourikian,V. Blanchette	48
11	Short-Term Exposure of Cartilage to Blood Results in Chondrocyte Apoptosis 2003 ·American Journal Of Pathology ·(unknown),G. Roosendaal,M. J. G. Wenting,Marijke van den Berg,J. W. J. Bijlsma,Floris P. J. G. Lafeber	138
12	Blood-induced joint damage: longterm effects in vitro and in vivo. 2003 ·PubMed ·(unknown),G. Roosendaal,Marieke E. Vianen,Marijke van den Berg,J. W. J. Bijlsma,Floris P. J. G. Lafeber	105
13	Pilot testing of the ‘Haemo‐QoL’ quality of life questionnaire for haemophiliac children in six European countries 2002 ·Haemophilia ·Monika Bullinger,Sylvia von Mackensen,Kathelijn Fischer,Kate Khair,Corinna Petersen,Ulrike Ravens‐Sieberer,Angiola Rocino,Pierre‐Philippe Sagnier,J Tusell,Marijke van den Berg,M Vicariot	78
14	The Defective Down Regulation of Fibrinolysis in Haemophilia A Can Be Restored by Increasing the TAFI Plasma Concentration 2001 ·Thrombosis and Haemostasis ·Laurent O. Mosnier,Ton Lisman,Marijke van den Berg,(unknown),Joost C.M. Meijers,Bonno N. Bouma	94
15	Evaluation of the Dutch Version of the Migraine Quality of Life Instrument (Msqol) and Its Application in Headache Coping 2001 ·Cephalalgia ·Jan Passchier,(unknown),SP McKenna,Marijke van den Berg,(unknown)	22
16	Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency 2001 ·Blood ·Richard van Wijk,(unknown),Marijke van den Berg,Eric G. Huizinga,(unknown),Rob J. Kraaijenhagen,Wouter W. van Solinge	58
17	Treatment of children with haemophilia in Europe: a survey of 20 centres in 16 countries 2000 ·Haemophilia ·Rolf Ljung,(unknown),(unknown),Marijke van den Berg,Hérvè Chambost,S. Claeyssens,Chris Van Geet,Anders Glomstein,Ian Hann,F. G. H. Hill,Rainer Kobelt,W. Kreuz,Giuseppe Mancuso,W. Muntean,Pia Petrini,(unknown),E. Scheibel,MA Siimes,Owen Smith,J Tusell	58
18	Port‐A‐Cath usage in children with haemophilia: experience of 53 cases 1998 ·Acta Paediatrica ·Rolf Ljung,Marijke van den Berg,Pia Petrini,Lilian Tengborn,E. Scheibel,Riitta Kekomäki,W. Effenberger	74
19	The Nijmegen Modification of the Bethesda Assay for Factor VIII:C Inhibitors: Improved Specificity and Reliabilitybreakdown → 1995 ·Thrombosis and Haemostasis ·Bert Verbruggen,I.R.O. Nováková,H. Wessels,J.B.M. Boezeman,Marijke van den Berg,Eveline P. Mauser‐Bunschoten	500
20	Collaboration between a children's hospital and a psychiatric clinic for children in the treatment of ulcerative colitis. 1952 ·PubMed ·(unknown),(unknown),(unknown),Suzette Glasner,Marijke van den Berg,(unknown)	0

About Marijke van den Berg

Marijke van den Berg is a scholar working on Hematology, Genetics and Speech and Hearing, having authored 24 papers that have together received 1.8k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (18 papers), Blood Coagulation and Thrombosis Mechanisms (8 papers) and Platelet Disorders and Treatments (7 papers). The work is most often cited by research in Hematology (1.6k citations), Genetics (473 citations) and Internal Medicine (34 citations). Marijke van den Berg has collaborated with scholars based in Netherlands, Sweden and Germany. Frequent co-authors include Eveline P. Mauser‐Bunschoten, I.R.O. Nováková, Bert Verbruggen, H. Wessels, J.B.M. Boezeman, G. Roosendaal, Pia Petrini, Floris P. J. G. Lafeber, J. W. J. Bijlsma and Kathelijn Fischer. Their work appears in journals such as Blood, American Journal Of Pathology and Thrombosis and Haemostasis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact